Qiagen NV (LTS:0RLT)
€ 43.54 0 (0%) Market Cap: 9.16 Bil Enterprise Value: 9.58 Bil PE Ratio: 106.36 PB Ratio: 2.73 GF Score: 85/100

Qiagen NV Annual Shareholders Meeting Transcript

Jun 22, 2023 / 08:00AM GMT
Release Date Price: €42.38 (-0.33%)
Lawrence A. Rosen
Qiagen N.V. - Independent Chairman of Supervisory Board

Ladies and gentlemen, let me welcome you to this Annual General Meeting of QIAGEN. My name is Larry Rosen, and I am Chair of the Supervisory Board. Here on the podium, I'm joined by 3 colleagues from the Supervisory Board. Dr. Metin Colpan, Chair of the Science and Technology Committee and Co-Founder of QIAGEN; Dr. Toralf Haag, the Chair of the Audit Committee; and Professor Dr. Ross Levine, a member of the Supervisory Board, who also serves as the Chair of our Scientific Advisory Board.

We have other members of the Supervisory Board, Professor Dr. Elaine Mardis; and Dr. Eva Pisa, joining us online. Also joining us on the podium are 2 managing Board members, Mr. Thierry Bernard, our CEO; and Mr. Roland Sackers, our CFO. I would also like to introduce Mr. Casper Nagtegaal and Mr. Lars Buiten from our law firm, De Brauw Blackstone, Westbrook NV; and Mr. Rene Meester and Ms. Magda De Bruyn from KPMG, our auditors. I'd also like to note the attendance of Professor Dr. [Detlef Wesner] in the audience. Professor Wesner was one

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot